Lindahl acted as legal advisor to Corline Biomedical
Through the agreement, Imperative Care is given the exclusive right to use CHS™ in all types of neurovascular products given a certain level of compensation. Corline undertakes to supply CHS™-coated products according to defined specifications, but also to assist in further development and market registration of the current product. In addition, Corline will participate in the development of additional CHS™-coated products within the indication area. These products have the potential to generate revenue for Corline of approximately SEK 150 million per year and a total of more than SEK 1 billion.
Lindahl's team consisted of Hugo Norlén and Erika Svensson.
Corline's press release (in Swedish) is available here.
Do you want to know more? Contact:
Hugo Norlén
Partner | AdvokatErika Svensson
Partner | AdvokatCarousel items
-
Cases and transactions
9/15/2025
Lindahl advises Hines on the acquisition of eight industrial properties
Lindahl has advised Hines and its fund, Hines European Core Fund (HECF), on the acquisition of a portfolio of eight industrial properties in the Stockholm and Gothenburg regions.
-
Knowledge
9/8/2025
How the CJEU ruling affects your handling of pseudonymised data
A new ruling by the Court of Justice of the European Union clarifies what constitutes personal data and clarifies the conditions under which companies can use pseudonymised data. Here's what you need to know - and what new opportunities it could o...
-
Portraits
8/19/2025
From demand letters to culture – Josefin on life as a summer trainee
Getting a real feel for what it's like to work as a lawyer was Josefin Mannevik's goal when she joined Lindahl's Gothenburg office as a summer trainee. A few weeks later, she has not only immersed herself in bankruptcy law, legal monitoring and si...
-
News articles
8/18/2025
Lindahl wins in the Supreme Court - bankruptcy cancelled for debt-free company
Lindahl has successfully represented ParkingSolar Nordic AB in a bankruptcy dispute that was decided in the company's favour by the Supreme Court. The case raises important questions about when presumption rules for insolvency can be applied.
-
Read more news and insights?
